Smad3 is necessary for transforming growth factor-beta2 induced ocular hypertension in mice

Experimental Eye Research

Volumn 116, Issue , 2013, Pages 419-423

  McDowell, Colleen M ^a   Tebow, Holly E ^a   Wordinger, Robert J ^a   Clark, Abbot F ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Glaucoma; Mouse model; Ocular hypertension; TGF 2 signaling; Trabecular meshwork

Indexed keywords

ADENOVIRUS VECTOR; FIBRONECTIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK;

GLAUCOMA; MOUSE MODEL; OCULAR HYPERTENSION; TGFΒ2 SIGNALING; TRABECULAR MESHWORK;

ANIMALS; GENE EXPRESSION REGULATION; GENETIC VECTORS; MICE; OCULAR HYPERTENSION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84887548100     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.10.017     Document Type: Article

References (30)

1. Flanders K.C. Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 2004, 85:47-64.
2. Fleenor D.L., Shepard A.R., Hellberg P.E., Jacobson N., Pang I.H., Clark A.F. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2006, 47:226-234.
3. Fuchshofer R., Tamm E.R. The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 2012, 347:279-290.
4. Fuchshofer R., Yu A.H., Welge-Lussen U., Tamm E.R. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:715-726.
5. Gottanka J., Chan D., Eichhorn M., Lutjen-Drecoll E., Ethier C.R. Effects of TGF-beta2 in perfused human eyes. Invest. Ophthalmol. Vis. Sci. 2004, 45:153-158.
6. Inatani M., Tanihara H., Katsuta H., Honjo M., Kido N., Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:109-113.
7. Javelaud D., Mauviel A. Mammalian transforming growth factor-betas: smad signaling and physio-pathological roles. Int. J. Biochem. Cell Biol. 2004, 36:1161-1165.
8. Javelaud D., Mauviel A. Transforming growth factor-betas: smad signaling and roles in physiopathology. Pathol. Biol. (Paris) 2004, 52:50-54.
9. Javelaud D., Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 2005, 24:5742-5750.
10. Kim C.Y., Kuehn M.H., Anderson M.G., Kwon Y.H. Intraocular pressure measurement in mice: a comparison between Goldmann and rebound tonometry. Eye (Lond) 2007, 21:1202-1209.
11. Lutjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog. Retin. Eye Res. 1999, 18:91-119.
12. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1:169-178.
13. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 2000, 14:627-644.
14. McDowell C.M., Luan T., Zhang Z., Putliwala T., Wordinger R.J., Millar J.C., John S.W., Pang I.H., Clark A.F. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice. Exp. Eye Res. 2012, 100:65-72.
15. Millar J.C., Pang I.H., Wang W.H., Wang Y., Clark A.F. Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment. Mol. Vis. 2008, 14:10-19.
16. Ochiai Y., Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn. J. Ophthalmol. 2002, 46:249-253.
17. Ozcan A.A., Ozdemir N., Canataroglu A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int. Ophthalmol. 2004, 25:19-22.
18. Quigley H.A. Open-angle glaucoma. N.Engl. J. Med. 1993, 328:1097-1106.
19. Roberts A.B., Russo A., Felici A., Flanders K.C. Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann. N. Y. Acad. Sci. 2003, 995:1-10.
20. Rohen J.W., Witmer R. Electrn microscopic studies on the trabecular meshwork in glaucoma simplex. Albrecht Von Graefes Arch. Klin Exp. Ophthalmol. 1972, 183:251-266.
21. Savinova O.V., Sugiyama F., Martin J.E., Tomarev S.I., Paigen B.J., Smith R.S., John S.W. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001, 2:12.
22. Sethi A., Jain A., Zode G.S., Wordinger R.J., Clark A.F. Role of TGFbeta/Smad signaling in gremlin induction of human trabecular meshwork extracellular matrix proteins. Invest. Ophthalmol. Vis. Sci. 2011, 52:5251-5259.
23. Shepard A.R., Jacobson N., Millar J.C., Pang I.H., Steely H.T., Searby C.C., Sheffield V.C., Stone E.M., Clark A.F. Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum. Mol. Genet. 2007, 16:609-617.
24. Shepard A.R., Millar J.C., Pang I.H., Jacobson N., Wang W.H., Clark A.F. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest. Ophthalmol. Vis. Sci. 2010, 51:2067-2076.
25. Tovar-Vidales T., Clark A.F., Wordinger R.J. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Exp. Eye Res. 2011, 93:442-451.
26. Tripathi R.C., Li J., Chan W.F., Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 1994, 59:723-727.
27. Verrecchia F., Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J.Invest. Dermatol. 2002, 118:211-215.
28. Welge-Lussen U., May C.A., Eichhorn M., Bloemendal H., Lutjen-Drecoll E. AlphaB-crystallin in the trabecular meshwork is inducible by transforming growth factor-beta. Invest. Ophthalmol. Vis. Sci. 1999, 40:2235-2241.
29. Wordinger R.J., Fleenor D.L., Hellberg P.E., Pang I.H., Tovar T.O., Zode G.S., Fuller J.A., Clark A.F. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest. Ophthalmol. Vis. Sci. 2007, 48:1191-1200.
30. Zode G.S., Sethi A., Brun-Zinkernagel A.M., Chang I.F., Clark A.F., Wordinger R.J. Transforming growth factor-beta2 increases extracellular matrix proteins in optic nerve head cells via activation of the Smad signaling pathway. Mol. Vis. 2011, 17:1745-1758.